← FDA DRUG APPROVALS

FDA ANDA · ANDA090888

METFORMIN HCL

Sponsor: MARKSANS PHARMA

APPLICATION
ANDA090888
TYPE
ANDA
ORIGINAL APPROVAL
2012-03-12
LATEST ACTION
2019-02-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

METFORMIN HYDROCHLORIDEPrescription
METFORMIN HYDROCHLORIDE 1GM · TABLET · ORAL
METFORMIN HYDROCHLORIDEPrescription
METFORMIN HYDROCHLORIDE 500MG · TABLET · ORAL
METFORMIN HYDROCHLORIDEPrescription
METFORMIN HYDROCHLORIDE 850MG · TABLET · ORAL

Approval history

2019-02-22Labeling · Supplement 4 · standardAP
2014-12-22Manufacturing (CMC) · Supplement 1 · unknownAP
2012-03-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →